Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

NCT00002907 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: bryostatin 1

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]